DNA Damage-Induced HSPC Malfunction Depends on ROS Accumulation Downstream of IFN-1 Signaling and Bid Mobilization

Area of Science:

• Hematology
• Molecular Biology
• Immunology

Background:

• DNA damage response (DDR) defects in hematopoietic stem and progenitor cells (HSPCs) lead to common, poorly understood malfunctions.
• Mixed-Lineage-Leukemia-5 (Mll5)-deficient mice serve as a model for studying these DDR-associated HSPC defects.

Purpose of the Study:

• To elucidate the molecular mechanisms linking DNA damage to HSPC malfunction.
• To identify key pathways and molecules involved in DDR-induced hematopoietic defects.

Main Methods:

• Utilized Mll5-deficient mice to investigate DNA damage and reactive oxygen species (ROS) accumulation in HSPCs.
• Assessed the impact of ROS reduction and genetic modifications (Ink4a/Arf locus, Bid, type 1 interferon signaling) on HSPC function.
• Analyzed the role of Bid and type 1 interferon signaling in mediating ROS production and HSPC defects.

Main Results:

• Mll5 deficiency causes DNA damage and ROS accumulation in HSPCs, leading to hematopoietic defects.
• Reducing ROS levels effectively reverses these hematopoietic defects, highlighting ROS as a critical factor.
• Type 1 interferon (IFN-1) signaling drives toxic ROS levels in Mll5-deficient HSPCs by promoting mitochondrial Bid accumulation.
• Genetic inactivation of Bid significantly reduces ROS and rescues HSPC defects in Mll5-/- mice.

Conclusions:

• Identified a novel IFN-1 > Bid > ROS pathway critical for DNA damage-associated HSPC malfunction.
• Demonstrated that ROS is a major driver of hematopoietic defects in Mll5-deficient mice.
• Findings provide mechanistic insight into HSPC dysfunction and suggest potential therapeutic targets for related disorders.